Avertissement ! Le contenu de cette page est disponible uniquement dans les langues suivantes: Anglais
Comecer is glad to be part of the Advanced Therapies Week 2022 on January 25th – 28th, at the Miami Beach Convention Center.
You will find our experts Ken Rando, Head of Business Development for Cell & Gene Therapy, North America, and Bill Guilfoile, Director of Comecer North America at tabletop #328.
They will be glad to answer all your questions.
Don’t miss Ken Rando’s presentation at 4.20 pm EST on January 27th in the Downstream Processing Session: « Flexible and modular cell processing and filling options for a shorter time to market of Cell & Gene applications. »
The main themes of his speech are:
• Time to market is an essential requirement for quick commercialization of C&G processes
• Flexibility and modularity help to adapt manufacturing to different processing needs in all process phases
• A successful combination of processing and filling is a key step for being ready for market approval. Focus on ValueCell as a modular system adaptable to the different phases of the process as it is applicable in filling/downstream/upstream/processing